This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignee: Csl Limited. Active years: 2010-2012.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Victoria, AU (2010)
- Bullengarook, AU (2012)
Company Filing History:
Years Active: 2010-2012
Title: Debbie Pauline Drane: Innovator in Immunogenic Complexes
Introduction
Debbie Pauline Drane is a notable inventor based in Bullengarook, Australia. She has made significant contributions to the field of immunology through her innovative work on immunogenic complexes. With a total of 2 patents, Drane's inventions focus on enhancing therapeutic and prophylactic responses to antigens.
Latest Patents
Drane's latest patents include groundbreaking work on immunogenic complexes. The first patent describes an immunogenic complex comprising a charged organic carrier and a charged antigen, specifically a negatively charged organic carrier and a positively charged antigen. These complexes are designed to facilitate the induction of a cytotoxic T-lymphocyte response to an antigen, making them valuable as therapeutic agents. The second patent reiterates similar concepts, emphasizing the utility of these complexes in inducing immune responses.
Career Highlights
Debbie Pauline Drane is associated with CSL Limited, a leading global biotechnology company. Her work at CSL Limited has allowed her to focus on developing innovative solutions in the field of immunology. Drane's research has the potential to impact therapeutic strategies significantly.
Collaborations
Drane has collaborated with esteemed colleagues, including John Cooper Cox and Andreas Suhrbier. These collaborations have further enriched her research and contributed to the advancement of her innovative projects.
Conclusion
Debbie Pauline Drane's contributions to immunogenic complexes highlight her role as a pioneering inventor in the field of immunology. Her work continues to pave the way for advancements in therapeutic and prophylactic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
